30 Day FDA Drug Development in Ca...

30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 22 Clinical Trial Design Nuances for Cannabinoid Therapies

Cannabinoid and Psychedelic Pharmacology and Drug Developmen... by Jim Mitchell and Google NotebookLM
S4 · E25
Jan 31, 2025
21:44

Episode notes

This podcast episode explores the complexities and challenges of clinical trials for cannabinoid therapies. The discussion covers key aspects including:

- Dosing variability and product consistency challenges in plant-derived compounds

- Patient compliance and addressing stigma around cannabis research

- Placebo control difficulties unique to cannabinoid studies

- Special considerations for vulnerable populations like children and pregnant women

The episode also examines promising therapeutic applications including chronic pain management, multiple sclerosis treatment, and potential cancer-related applications.